Anthropic confirms $83 IPO price on 980 million shares in an $81 billion deal

The size of the deal is the main market story. Absorbing roughly $81 billion of new stock, and potentially more if the over-allotment option is used, draws liquidity from elsewhere. That could weigh on other AI and mega-cap tech names in the short term as funds rebalance to make room. A strong debut would likely help neocloud and AI infrastructure stocks, which sold off this week on funding worries, while a weak one would reinforce them. The over-allotment option also gives underwriters a tool to support the price in the early days of trading, which may soften any initial volatility.

—

Anthropic’s official numbers confirm a deal of extraordinary size, with roughly $79 billion going straight to the company. Whether public markets can digest it will be clear once ANT opens on Thursday.

Summary:

  • Anthropic priced its IPO at $83 per share (earlier tip on this), above the $70 to $78 range, selling 980 million Class A shares
  • About 956 million shares are new, raising roughly $79 billion for Anthropic, and selling stockholders are offering about 24 million shares
  • Underwriters have a 30-day option to buy up to 147 million more shares, which would take the deal to about $93.5 billion
  • Trading on the Nasdaq Global Select Market under the ticker ANT is due to begin Thursday, November 19, with no scheduled time for the first trade
  • The offering is expected to close on November 20, and the announcement gave no valuation or use of proceeds


Anthropic has confirmed
the pricing of its initial public offering at $83 per share, selling 980 million Class A shares in a deal worth around $81 billion before any additional shares are sold, the company said in an announcement on Wednesday. Trading is due to begin on the Nasdaq Global Select Market under the ticker ANT on Thursday, November 19. As with any IPO, there is no scheduled time for the first trade: the stock opens once enough buy and sell orders have been matched to set an opening price, which can happen anywhere from minutes to hours after the regular session begins.

Most of the shares on offer are new. Anthropic is selling about 956 million shares itself, which at the offer price would raise roughly $79 billion for the company, while existing shareholders are selling about 24 million shares, worth around $2 billion. Anthropic will not receive any proceeds from the shares sold by those stockholders. The underwriters also have a 30-day option to buy up to 147 million additional shares, equal to 15% of the base deal. If that option is exercised in full, the total offering would rise to around $93.5 billion.

The $83 price sits above the $70 to $78 range Anthropic set last week, a sign that institutional demand outstripped the shares on offer. The Securities and Exchange Commission declared the registration statement effective on Wednesday, and the offering is expected to close on Friday, November 20, subject to customary conditions. Goldman Sachs and Morgan Stanley are named in the announcement as sources for copies of the final prospectus.

The company’s announcement did not set out a valuation or say how it plans to use the money. It did restate that Anthropic is a public benefit corporation, with a stated mission of developing and maintaining advanced AI responsibly for the long-term benefit of humanity. That structure gives the board a legal duty to weigh its mission alongside shareholder returns, a point new investors will need to factor in when judging how the company balances growth, safety and profit.

The scale of the raise is striking even by the standards of the AI boom, and it arrives at a fragile moment. AI stocks have been hit in recent days by worries over rising interest rates, new US curbs on chip sales and the leadership crisis at Nvidia, whose shares fell to a 16-month low on Wednesday. How ANT trades on its first day will be read well beyond Anthropic: a firm debut would suggest public markets are still willing to fund the AI build-out at scale, while a weak one would add to the doubts that have been building across the sector. 

This article was written by Eamonn Sheridan at investinglive.com.

Leave a Reply